Skip to content
DNDi Logo
  • DNDi JAPAN
  • DNDi LATIN AMERICA
  • DNDi NORTH AMERICA
  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Menu
  • ABOUT US
        • ABOUT US
        • BUSINESS MODEL
        • DNDi‘s POLICIES
        • DNDi WORLDWIDE
        • OUR PEOPLE
        • ANNUAL REPORTS
        • JOB OPPORTUNITIES
        • REQUESTS FOR PROPOSALS
        • CONTACT US
    • Close
  • DISEASES & PROJECTS
        • DISEASES
        • SLEEPING SICKNESS
        • LEISHMANIASIS
        • CHAGAS DISEASE
        • PAEDIATRIC HIV
        • FILARIAL DISEASE
        • MYCETOMA
        • HEPATITIS C
        • PROJECT PORTFOLIO
        • TARGET PRODUCT PROFILES
        • CLINICAL TRIALS
        • OPEN INNOVATION PORTAL
    • Close
  • ACHIEVEMENTS
      • DNDi ACHIEVEMENTS
      • FEXINIDAZOLE
        Sleeping sickness
      • GLOBAL ANTIBIOTIC R&D PARTNERSHIP (GARDP)
      • SUPER-BOOSTER THERAPY
        Paediatric HIV/TB
      • NEW VL TREATMENTS SOUTH ASIA
        Visceral leishmaniasis
      • PAEDIATRIC BENZNIDAZOLE
        Chagas
      • SSG&PM
        Visceral leishmaniasis
      • NECT
        Sleeping sickness
      • ASMQ
        Malaria
      • ASAQ
        Malaria
    • Close
  • STRENGTHENING CAPACITY
        • OVERVIEW
        • TECHNOLOGY TRANSFERS
        • CHAGAS PLATFORM
        • HAT PLATFORM
        • LEAP PLATFORM
        • REDELEISH NETWORK
    • Close
  • ADVOCACY
      • ADVOCACY UPDATES
      • ACCESS
      • INTELLECTUAL PROPERTY
    • Close
  • NEWS & RESOURCES
        • OVERVIEW
        • NEWS, VIEWS & STORIES
        • PRESS RELEASES
        • IN THE MEDIA
        • OUR PUBLICATIONS
        • ENEWS NEWSLETTER
        • VIDEOS
        • SCIENTIFIC ARTICLES
        • EVENTS
    • Close
  • PARTNERS
      • OVERVIEW
      • BUSINESS MODEL
      • PARTNERS
      • BECOME A DNDi PARTNER
    • Close
  • DONATE
      • DONATE
      • HOW TO HELP
      • DONORS
      • TRANSPARENCY
      • KEY FINANCIAL FIGURES
    • Close
    • Close
  • Home
  • Media Centre
  • In the Media

In the Media

El País [3 May, 2017]

“18 males, mil millones de enfermos” – “18 illnesses, 1 billion sick”

Click here to read the article

In the MediaChagas disease, Filarial diseases, Leishmaniasis, Mycetoma, Sleeping sickness (HAT), Treatment

Post navigation

Previous
El País: “El mal oculto de siete millones de latinos”
Next
El País: “Las picaduras que te dejan ciego”

News & Resources

  • Overview
  • News, Views & Stories
    • News
    • Viewpoints
    • Stories
  • Press Releases
    • Press Releases – Other Languages
    • 2019
    • 2018
    • 2017
    • 2016
    • Previous years
  • In the Media
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • Previous years
    • Radio
    • Television
  • Our Publications
  • Enews Newsletter
  • Videos
  • Scientific Articles
    • Human African Trypanosomiasis (Sleeping Sickness)
    • Visceral Leishmaniasis
    • Cutaneous Leishmaniasis
    • Filarial diseases
    • Chagas Disease
    • Mycetoma
    • Malaria
    • Neglected Diseases
    • Paediatric HIV
    • Hepatitis C
  • Events
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • Previous years

Recent Articles

  • The Guardian: “‘The job is not done’: the fight to combat neglected tropical diseases”
  • Forbes: “Global health technologes: Time to re-think the ‘Trickle Down’ model”
  • AllAfrica: “Africa: From London to Kigali – We must embrace change to beat NTDs”

Media Centre Search

Category
Diseases
Topic
Year

About DNDi

Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients’ needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for neglected patients.

Learn More

  • Vision & Mission
  • Business Plan
  • DNDi‘s Model
  • Diseases & Projects
  • Portfolio
  • Treatments developed
  • Clinical Trials
  • Annual Report
  • Scientific Articles
  • Contact Us

Work with Us

  • Donate
  • Partnership
  • Requests for Proposals
  • Jobs

DNDi Worldwide

  • DNDi regional offices
  • DNDi Japan のサイトへはこちらから.
  • DNDi Latin America website
  • DNDi North America website

Connect

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
  • Events

Newsletter

Sign up for the E-news newsletter! By subscribing, you agree that all info submitted will be processed according to our Privacy Policy. You can unsubscribe any time.

I want to receive

  • PRIVACY POLICY
  • TERMS OF USE
  • ACCEPTABLE USE POLICY
  • COOKIE POLICY
  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License
We use cookies to improve your experience with our website. By continuing to browse our website, you are agreeing to our use of cookies. However, you can change your cookie settings at any time in your browser. Read Cookie Policy. Close